QUETIAPINE INOVAMED SR 200 MG

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

QUETIAPINE AS FUMARATE

متاح من:

INOVAMED LTD

ATC رمز:

N05AH04

الشكل الصيدلاني:

TABLETS PROLONGED RELEASE

تركيب:

QUETIAPINE AS FUMARATE 200 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

PHARMATHEN S.A., GREECE

المجال العلاجي:

QUETIAPINE

الخصائص العلاجية:

Quetiapine Inovamed SR is indicated for the treatment of Schizophrenia. Quetiapine Inovamed SR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Inovamed SR. Quetiapine Inovamed SR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. Quetiapine Inovamed SR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Inovamed SR.

تاريخ الترخيص:

2020-11-02

نشرة المعلومات

PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed without a doctor's prescription
LEMOCIN LEMON
LEMOCIN CHERRY
LOZENGES
ACTIVE INGREDIENTS AND THEIR QUANTITIES:
Each lozenge contains:
lidocaine 1 mg
tyrothricin 4 mg
cetrimonium bromide 2 mg
Inactive ingredients and allergens: See section 2 under "Important
information about some of
this medicine’s ingredients" and section 6 "Additional information".
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE. This leaflet
contains concise information about this medicine. If you have any
further questions, consult
your doctor or pharmacist. Use the medicine according to the
instructions provided in the
dosage section of this leaflet. Consult your pharmacist if you need
further information.
Contact your doctor if disease symptoms are worsening or do not
improve after 5-7 days.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
Lemocin is a lozenge for relief of severe sore throat and pain
associated with oral infections.
The medicine is intended for adults and children above the age of 12
years.
THERAPEUTIC GROUP:
Lemocin contains lidocaine (local anaesthetic), tyrothricin
(antibiotic) and cetrimonium
bromide (antiseptic).
2.
BEFORE USING THIS MEDICINE
DO NOT USE THIS MEDICINE IF:
You are sensitive (allergic) to the active ingredients (lidocaine,
tyrothricin and cetrimonium
bromide) or to any of the other ingredients in this medicine (see
section 6).
SPECIAL WARNINGS ABOUT USING THIS MEDICINE
BEFORE USING LEMOCIN, TELL YOUR DOCTOR/PHARMACIST IF:
●
You have a sore throat accompanied by fever for several days,
●
You have a cut or injury in the mucosal lining of the mouth or throat,
●
The symptoms do not improve or persist for longer than 5-7 days,
●
You have a sore throat accompanied by high fever, dizziness, vomiting
or severe
discomfort upon swallowing.
Before using the medicine, inform your doctor/pharmacist if you have
any disease or if you
have previously experienced allergic reactions.
Do n